This likely dual role of PYCARD [apoptotic/tumor-suppressor vs. pro-inflammatory/oncogene (as happened with the above-mentioned AIM2)] in different cancer types has been recently reviewed [113]. This evidence concerns the gene PYCARD and neoplasm.